Literature DB >> 18380697

Prenatal thrombosis of torcular Herophili with spontaneous resolution and normal outcome.

Savvas Grigoriadis1, Jose E Cohen, John Moshe Gomori.   

Abstract

BACKGROUND: Prenatal thrombosis of torcular Herophili is a rare condition. It may be suspected during the routine ultrasonographic follow-up of the fetus, but MRI is necessary to establish the diagnosis. There are 7 reported cases with various results.
METHODS: We report a case of prenatal torcular Herophili thrombosis. We present 2 series of fetal MRIs. The first one was performed at 21 and the second at 37 weeks' gestation.
RESULTS: The second MRI revealed a total resolution of the thrombus. The product was a neurologically intact infant with normal development.
CONCLUSIONS: This is the fourth reported case of fetal torcular Herophili thrombosis with normal outcome. There are no sufficient data regarding the best management of this rare condition; however, following up with fetal MRIs seems to be the most rational choice.

Entities:  

Mesh:

Year:  2008        PMID: 18380697     DOI: 10.1111/j.1552-6569.2007.00166.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  3 in total

1.  In utero magnetic resonance imaging for diagnosis of dural venous sinus ectasia with thrombosis in the fetus.

Authors:  Evgenia Maria Fanou; Mike J Reeves; David T Howe; Harriet Joy; Susan Morris; Sarah Russell; Paul D Griffiths
Journal:  Pediatr Radiol       Date:  2013-10-15

2.  Prenatal diagnosis of cerebral venous pathologies: findings in diffusion-weighted imaging (DWI), time-of-flight (TOF), and gradient-echo sequences.

Authors:  U A Ozcan; M E Yildiz; U Işik; A Dinçer
Journal:  Clin Neuroradiol       Date:  2013-03-24       Impact factor: 3.649

3.  Spontaneous Resolution of Congenital Dural Venous Sinus Ectasia Associated With Polymicrogyria-Case Report.

Authors:  Zuzanna Kozłowska; Paulina Komasińska; Barbara Steinborn; Kinga Toboła-Wróbel; Marek Pietryga; Marta Szymankiewicz-Breborowicz; Tomasz Szczapa; Monika Bekiesińska-Figatowska
Journal:  Front Pediatr       Date:  2022-02-28       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.